While the growth of big data and analytics help businesses understand their customers, serve better ads, and sell more, in healthcare, these same methodologies and technologies have a real enduring, profound societal impact. Real-world data (RW) and real-world evidence (RWE), made possible by technology, are being used by pharmaceutical companies and the healthcare ecosystem to develop, evaluate, implement, and optimize new treatment approaches. Aetion is the RWD and RWE platform that enables the healthcare system to harness the power of data to shape the future of medicine. The platform is designed to accelerate the time to market without compromising scientific rigor. For example, the company partnered with the FDA to develop real-world analytics related to COVID and vaccines. AlleyWatch caught up with CEO Carolyn Magill to learn more about Aetion’s approach to RWD is enabling the healthcare system to make informed decisions, the company’s strategic, plans, latest round of fun
AlleyWatch
23.6% of all healthcare interactions were via telehealth during the first four months of the pandemic, up from just .3% for the same period in 2019. The transition to digital has largely been led by primary care access but what happens when you need to access a specialist. Summus Global is a virtual care platform focused on providing employees and their families with specialist access. The company partners with corporate health benefit providers and organizations to provide access to a network of 4000+ top-tier specialists across 48 hospitals without long-drawn-out waits. During the pandemic, Summus grew its membership base 11x.
AlleyWatch caught up with CEO and Founder